儿童糖尿病酮症酸中毒静脉补液速度与氯化钠浓度的临床试验
这项13中心随机对照试验采用2×2析因设计,将糖尿病酮症酸中毒患儿随机分配至0.9%或0.45%氯化钠及快速或慢速补液组。主要结局为治疗期间格拉斯哥昏迷评分连续两次低于14分。结果显示补液速度与氯化钠浓度均未显著影响神经系统结局。
要点
- 补液速度与氯化钠浓度对糖尿病酮症酸中毒患儿神经系统结局无显著影响。
- 格拉斯哥昏迷评分降至14分以下发生于3.5%的发作,临床明显脑损伤发生于0.9%的发作。
- 各治疗组在短期记忆、恢复后记忆与智商及严重不良事件方面均无显著差异。
核心结论
- 静脉补液速度与氯化钠浓度均未显著影响儿童糖尿病酮症酸中毒的神经系统结局。
研究设计与样本
- 13中心随机对照试验,采用2×2析因设计,比较0.9%或0.45%氯化钠及快速或慢速补液。
- 共报告1255名儿童的1389次糖尿病酮症酸中毒发作。
主要发现
- 格拉斯哥昏迷评分降至14分以下发生于48次发作(3.5%),临床明显脑损伤发生于12次发作(0.9%)。
- 各治疗组在格拉斯哥昏迷评分降至14分以下的比例、下降幅度及持续时间方面均无显著差异。
- 各治疗组在短期记忆测试、恢复后记忆与智商评分及临床明显脑损伤发生率方面均无显著差异。
- 除意识状态改变外的严重不良事件罕见,且在各治疗组间发生频率相似。
临床怎么用
- 对于儿童糖尿病酮症酸中毒,补液速度与氯化钠浓度的选择可不以神经系统结局为主要考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetic ketoacidosis in children may cause brain injuries ranging from mild to severe. Whether intravenous fluids contribute to these injuries has been debated for decades. METHODS: We conducted a 13-center, randomized, controlled trial that examined the effects of the rate of administration and the sodium chloride content of intravenous fluids on neurologic outcomes in children with diabetic ketoacidosis. Children were randomly assigned to one of four treatment groups in a 2-by-2 factorial design (0.9% or 0.45% sodium chloride content and rapid or slow rate of administration). The primary outcome was a decline in mental status (two consecutive Glasgow Coma Scale scores of <14, on a scale ranging from 3 to 15, with lower scores indicating worse mental status) during treatment for diabetic ketoacidosis. Secondary outcomes included clinically apparent brain injury during treatment for diabetic ketoacidosis, short-term memory during treatment for diabetic ketoacidosis, and memory and IQ 2 to 6 months after recovery from diabetic ketoacidosis. RESULTS: A total of 1389 episodes of diabetic ketoacidosis were reported in 1255 children. The Glasgow Coma Scale score declined to less than 14 in 48 episodes (3.5%), and clinically apparent brain injury occurred in 12 episodes (0.9%). No significant differences among the treatment groups were observed with respect to the percentage of episodes in which the Glasgow Coma Scale score declined to below 14, the magnitude of decline in the Glasgow Coma Scale score, or the duration of time in which the Glasgow Coma Scale score was less than 14; with respect to the results of the tests of short-term memory; or with respect to the incidence of clinically apparent brain injury during treatment for diabetic ketoacidosis. Memory and IQ scores obtained after the children's recovery from diabetic ketoacidosis also did not differ significantly among the groups. Serious adverse events other than altered mental status were rare and occurred with similar frequency in all treatment groups. CONCLUSIONS: Neither the rate of administration nor the sodium chloride content of intravenous fluids significantly influenced neurologic outcomes in children with diabetic ketoacidosis. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Health Resources and Services Administration; PECARN DKA FLUID ClinicalTrials.gov number, NCT00629707 .).
引用
- Kuppermann N, Ghetti S, Schunk JE, et al. Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis. N Engl J Med. 2018. PMID: 29897851. doi:10.1056/NEJMoa1716816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。